Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
BioAtla, Inc. (BCAB)
USD4.26
+0.20 (+4.93%)
US NASDAQ Healthcare Biotechnology
Address
11085 Torreyana Road 92121
San Diego, CA, US
San Diego, CA, US
CEO
Jay Short
Website
bioatla.com
IPO
2020-12-16
CIK 1826892 ISIN US09077B2034
Description
BioAtla Inc. is a biopharmaceutical firm currently in the clinical development phase, focused on creating highly specific and selective antibody-derived treatments designed to combat solid tumor cancers. The company's primary experimental therapeutic, BA3011, is a conditionally active biologic antibody-drug conjugate (CAB ADC) being investigated for its potential against soft tissue and bone sarcoma, non-small cell lung cancer (NSCLC), and ovarian cancer. Additionally, BioAtla is advancing BA3021, another CAB ADC, for a variety of solid malignancies such as NSCLC, melanoma, and ovarian cancer. A third candidate, BA3071, is a conditionally active anti-cytotoxic T-lymphocyte-associated antigen 4 (CTLA-4) antibody aimed at a broad spectrum of cancers, including renal cell carcinoma, non-small cell and small cell lung cancers, hepatocellular carcinoma, melanoma, bladder cancer, gastric cancer, and cervical cancer. Established in 2007, BioAtla Inc. operates out of San Diego, California.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD4.26
+0.20 (+4.93%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
53.4K
Beta
0.77
Float Shares
998.3K
Free Float %
84.9%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -2.29% | -12.14% | -6.97% | -39.52% | -91.63% | -84.96% | -78.87% | -97.57% | -99.81% | -99.72% | -99.72% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (9 ratings, all time)
Buy
Price Targets & DCF
Current price
4.26
Low
250.00
+5,768.5%
Consensus
250.00
+5,768.5%
Median
250.00
+5,768.5%
High
250.00
+5,768.5%
Ratings Trend (MoM)
100% Bullish
| Rating | 2026-03 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 1 |
250.00
+5,768.5%
|
Quality scores
Altman Z-Score
-112.03
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
0 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
1 / 5
Low
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%-81.8%
-
EPS growth Biotechnology: +29.7%+29.9% ★ Q1'26: +67.5% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-2,732.8%
-
EBIT margin Biotechnology: +0.0%-2,965.3%
-
ROIC Biotechnology: -16.1%—
-
Share dilution Biotechnology: -3.4%+21.1% Q1'26: +28.9% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×-0.11× Q1'26: -0.16× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
429.0K
est: 450.3K (-4.7%)
|
250.0K
est: 1.22M (-79.5%)
|
—
est: 1.50M (-100.0%)
|
—
est: 3.00M (-100.0%)
|
11.00M
est: 11.00M (+0.0%)
|
2.00M
est: 2.87M (-30.2%)
|
19.70M
19.70M – 19.70M
+587.5% YoY
|
3.60M
3.60M – 3.60M
-81.7% YoY
|
54.60M
54.60M – 54.60M
+1,416.7% YoY
|
239.40M
239.40M – 239.40M
+338.5% YoY
|
| EBITDA |
-33.46M
est: -90.0K (-37,053.1%)
|
-94.07M
est: -244.0K (-38,453.0%)
|
-105.28M
est: -300.0K (-34,994.5%)
|
-122.24M
est: -600.0K (-20,273.5%)
|
-73.02M
est: -2.20M (-3,219.0%)
|
-58.93M
est: -573.1K (-10,183.0%)
|
-3.94M
-3.94M – -3.94M
-587.5% YoY
|
-720.0K
-720.0K – -720.0K
+81.7% YoY
|
-10.92M
-10.92M – -10.92M
-1,416.7% YoY
|
-47.88M
-47.88M – -47.88M
-338.5% YoY
|
| EBIT |
-34.46M
est: -90.0K (-38,172.5%)
|
-95.40M
est: -244.0K (-38,998.1%)
|
-106.48M
est: -300.0K (-35,394.1%)
|
-123.46M
est: -600.0K (-20,477.0%)
|
-73.94M
est: -2.20M (-3,261.0%)
|
-59.31M
est: -573.1K (-10,248.1%)
|
-3.94M
-3.94M – -3.94M
-587.5% YoY
|
-720.0K
-720.0K – -720.0K
+81.7% YoY
|
-10.92M
-10.92M – -10.92M
-1,416.7% YoY
|
-47.88M
-47.88M – -47.88M
-338.5% YoY
|
| Net Income |
-35.85M
est: -146.67M (+75.6%)
|
-95.40M
est: -134.07M (+28.8%)
|
-105.28M
est: -139.62M (+24.6%)
|
-123.46M
est: -134.18M (+8.0%)
|
-69.78M
est: -89.71M (+22.2%)
|
-59.61M
est: -63.53M (+6.2%)
|
-54.12M
-54.12M – -54.12M
+14.8% YoY
|
-68.83M
-68.83M – -68.83M
-27.2% YoY
|
-52.95M
-52.95M – -52.95M
+23.1% YoY
|
-56.47M
-56.47M – -56.47M
-6.7% YoY
|
| SGA |
10.60M
est: 16.42M (-35.5%)
|
38.42M
est: 44.49M (-13.7%)
|
28.79M
est: 54.70M (-47.4%)
|
25.96M
est: 109.41M (-76.3%)
|
21.85M
est: 366.34M (-94.0%)
|
17.73M
est: 95.43M (-81.4%)
|
656.07M
656.07M – 656.07M
+587.5% YoY
|
119.89M
119.89M – 119.89M
-81.7% YoY
|
1.82B
1.82B – 1.82B
+1,416.7% YoY
|
7.97B
7.97B – 7.97B
+338.5% YoY
|
| EPS |
-53.00
est: -3.02 (-1,655.3%)
|
-138.00
est: -2.76 (-4,899.7%)
|
-137.00
est: -2.87 (-4,666.3%)
|
-129.00
est: -2.76 (-4,569.7%)
|
-72.00
est: -76.25 (+5.6%)
|
-50.50
est: -54.00 (+6.5%)
|
-46.00
-46.00 – -46.00
+14.8% YoY
|
-58.50
-58.50 – -58.50
-27.2% YoY
|
-45.00
-45.00 – -45.00
+23.1% YoY
|
-48.00
-48.00 – -48.00
-6.7% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-11 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-08 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-29 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-28 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-27 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-24 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-23 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-22 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-21 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-17 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-16 | C | 2/5 | 1/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-87.87M
OE per share TTM
-75.09
Owner's Yield
-1,652.37%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
163.0%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
9
Total invested
473.5K
Insider transactions (90d)
0
Beneficial owners (>5%)
50
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Wellington Group Holdings LLP | 3.23M | 9.15% | — | 2.86M | — | — | HC | Delaware | 2022-02-04 | ↗ |
| 2 | Wellington Investment Advisors Holdings LLP | 3.23M | 9.15% | — | 2.86M | — | — | HC | Delaware | 2022-02-04 | ↗ |
| 3 | Wellington Management Group LLP | 3.23M | 9.15% | — | 2.86M | — | — | HC | Massachusetts | 2022-02-04 | ↗ |
| 4 | GUY LEVY | 3.19M | 9.93% | 14.9K | 3.18M | 14.9K | 3.18M | IN | — | 2020-12-28 | ↗ |
| 5 | Wellington Management Company LLP | 3.01M | 8.51% | — | 2.82M | — | — | IA | Delaware | 2022-02-04 | ↗ |
| 6 | (1) BlackRock, Inc. | 2.88M | 6.00% | 2.83M | — | 2.88M | — | HC | Delaware | 2024-01-29 | ↗ |
| 7 | Anders Hove | 2.73M | 5.70% | — | 2.73M | — | — | IN | United States of America | 2023-04-27 | ↗ |
| 8 | HBM Healthcare Investments (Cayman) Ltd. | 2.69M | 8.80% | 2.69M | — | 2.69M | — | CO | Cayman Islands, British West Indies | 2020-12-28 | ↗ |
| 9 | Israel A. Englander | 2.41M | 5.00% | — | 2.41M | — | 2.41M | IN | Delaware | 2024-08-07 | ↗ |
| 10 | Millennium Group Management LLC | 2.41M | 5.00% | — | 2.41M | — | 2.41M | OO | Delaware | 2024-08-07 | ↗ |
| 11 | Millennium Management LLC | 2.41M | 5.00% | — | 2.41M | — | 2.41M | OO | Delaware | 2024-08-07 | ↗ |
| 12 | Bihua Chen | 2.29M | 7.12% | — | 2.29M | — | 2.29M | IN | Cayman Islands | 2020-12-28 | ↗ |
| 13 | Cormorant Asset Management, LP | 2.29M | 7.12% | — | 2.29M | — | 2.29M | PN | Cayman Islands | 2020-12-28 | ↗ |
| 14 | The Vanguard Group - 23-1945930 | 2.26M | 6.41% | — | 30.8K | 2.22M | 44.5K | IA | Pennsylvania | 2022-02-09 | ↗ |
| 15 | Pfizer Inc. | 2.24M | 7.00% | — | 2.24M | — | — | CO | Delaware | 2021-02-16 | ↗ |
| 16 | Pfizer Ventures (US) LLC | 2.24M | 7.00% | — | 2.24M | — | — | OO | Delaware | 2021-02-16 | ↗ |
| 17 | SOLEUS PE GP I, LLC | 2.12M | 6.60% | — | 2.12M | — | 2.12M | OO | — | 2020-12-28 | ↗ |
| 18 | SOLEUS PRIVATE EQUITY GP I, LLC | 2.12M | 6.60% | — | 2.12M | — | 2.12M | OO | — | 2020-12-28 | ↗ |
| 19 | Andrew J. M. Spokes | 1.97M | 6.10% | — | 1.97M | — | — | IN | United Kingdom | 2020-12-28 | ↗ |
| 20 | David T. Kim | 1.97M | 6.10% | — | 1.97M | — | — | IN | United States | 2020-12-28 | ↗ |
| 21 | John R. Warren | 1.97M | 6.10% | — | 1.97M | — | — | IN | United States | 2020-12-28 | ↗ |
| 22 | Michael G. Linn | 1.97M | 6.10% | — | 1.97M | — | — | IN | United States | 2020-12-28 | ↗ |
| 23 | Philip D. Dreyfuss | 1.97M | 6.10% | — | 1.97M | — | — | IN | United States | 2020-12-28 | ↗ |
| 24 | Richard B. Fried | 1.97M | 6.10% | — | 1.97M | — | — | IN | United States | 2020-12-28 | ↗ |
| 25 | SOLEUS PRIVATE EQUITY FUND I, L.P. | 1.79M | 5.57% | — | 1.79M | — | 1.79M | PN | — | 2020-12-28 | ↗ |
| 26 | Abigail P. Johnson | 1.78M | 5.53% | — | — | 1.78M | — | IN | United States of America | 2021-02-08 | ↗ |
| 27 | FMR LLC | 1.78M | 5.53% | 496.9K | — | 1.78M | — | HC | Delaware | 2021-02-08 | ↗ |
| 28 | Farallon Capital Management, L.L.C. | 1.73M | 5.40% | — | 1.73M | — | — | OO | Delaware | 2020-12-28 | ↗ |
| 29 | Zone II Healthcare Holdings, LLC | 1.73M | 5.40% | — | 1.73M | — | — | OO | Delaware | 2020-12-28 | ↗ |
| 30 | Acorn Bioventures 2 L.P. | 1.41M | 3.00% | — | 1.41M | — | — | PN | United States of America | 2023-04-27 | ↗ |
| 31 | Acorn Capital Advisors GP 2, LLC | 1.41M | 3.00% | — | 1.41M | — | — | OO | United States of America | 2023-04-27 | ↗ |
| 32 | Acorn Bioventures, L.P. | 1.31M | 2.80% | — | 1.31M | — | — | PN | United States of America | 2023-04-27 | ↗ |
| 33 | Acorn Capital Advisors GP, LLC | 1.31M | 2.80% | — | 1.31M | — | — | OO | United States of America | 2023-04-27 | ↗ |
| 34 | Cormorant Private Healthcare Fund II, LP | 1.18M | 3.67% | — | 1.18M | — | 1.18M | PN | Cayman Islands | 2020-12-28 | ↗ |
| 35 | Cormorant Private Healthcare GP II, LLC | 1.18M | 3.67% | — | 1.18M | — | 1.18M | OO | Cayman Islands | 2020-12-28 | ↗ |
| 36 | Cormorant Global Healthcare GP, LLC | 1.08M | 3.34% | — | 1.08M | — | 1.08M | OO | Cayman Islands | 2020-12-28 | ↗ |
| 37 | Cormorant Global Healthcare Master Fund, LP | 1.08M | 3.34% | — | 1.08M | — | 1.08M | PN | Cayman Islands | 2020-12-28 | ↗ |
| 38 | SOLEUS CAPITAL GROUP, LLC | 1.06M | 3.28% | — | 1.06M | — | 1.06M | OO | — | 2020-12-28 | ↗ |
| 39 | SOLEUS CAPITAL MASTER FUND, L.P. | 1.06M | 3.28% | — | 1.06M | — | 1.06M | FI | — | 2020-12-28 | ↗ |
| 40 | SOLEUS CAPITAL, LLC | 1.06M | 3.28% | — | 1.06M | — | 1.06M | OO | — | 2020-12-28 | ↗ |
| 41 | SOLEUS BA SPV, LLC | 333.3K | 1.04% | — | 333.3K | — | 333.3K | OO | — | 2020-12-28 | ↗ |
| 42 | Farallon Partners, L.L.C. | 226.3K | 0.70% | — | 226.3K | — | — | OO | Delaware | 2020-12-28 | ↗ |
| 43 | Farallon Capital Offshore Investors II, L.P. | 109.4K | 0.30% | — | 109.4K | — | — | PN | Cayman Islands | 2020-12-28 | ↗ |
| 44 | Farallon Capital Institutional Partners, L.P. | 54.0K | 0.20% | — | 54.0K | — | — | PN | California | 2020-12-28 | ↗ |
| 45 | Farallon Capital Partners, L.P. | 33.4K | 0.10% | — | 33.4K | — | — | PN | California | 2020-12-28 | ↗ |
| 46 | Farallon Capital F5 Master I, L.P. | 11.2K | 0.00% | — | 11.2K | — | — | PN | Cayman Islands | 2020-12-28 | ↗ |
| 47 | Farallon F5 (GP), L.L.C. | 11.2K | 0.00% | — | 11.2K | — | — | OO | Delaware | 2020-12-28 | ↗ |
| 48 | Farallon Capital Institutional Partners II, L.P. | 10.7K | 0.00% | — | 10.7K | — | — | PN | California | 2020-12-28 | ↗ |
| 49 | Farallon Institutional (GP) V, L.L.C. | 8.2K | 0.00% | — | 8.2K | — | — | OO | Delaware | 2020-12-28 | ↗ |
| 50 | Farallon Capital (AM) Investors, L.P. | 4.4K | 0.00% | — | 4.4K | — | — | PN | Delaware | 2020-12-28 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
9
-32 vs prev Q
New positions
4
Closed positions
36
Increased
5
Reduced
1
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | ACORN CAPITAL ADVISORS, LLC | 4.84M +— (+0.0%) | 2.76M -580.2K (-17.4%) | 8.23% -0.034 pp | 0.93% -0.760 pp | USD0.56 +1.8% | 5 qtrs — |
| 2 | VANGUARD GROUP INC | 1.95M +— (+0.0%) | 1.11M -233.5K (-17.4%) | 3.31% -0.014 pp | 0.00% +0.000 pp | USD21.70 -97.4% | 21 qtrs — |
| 3 | MARSHALL WACE, LLP | 891.6K +891.6K (+100.0%) | 508.2K +508.2K (+100.0%) | 1.52% +1.518 pp | 0.00% +0.001 pp | USD0.57 +0.0% | 6 qtrs — |
| 4 | MILLENNIUM MANAGEMENT LLC | 762.4K +421.1K (+123.4%) | 432.8K +198.0K (+84.3%) | 1.30% +0.714 pp | 0.00% +0.000 pp | USD0.62 -8.1% | 21 qtrs — |
| 5 | ACADIAN ASSET MANAGEMENT LLC | 757.7K -172.8K (-18.6%) | 429.0K -209.0K (-32.8%) | 1.29% -0.301 pp | 0.00% 0.000 pp | USD0.37 +54.1% | 9 qtrs — |
| 6 | RENAISSANCE TECHNOLOGIES LLC | 707.2K -93.4K (-11.7%) | 401.5K -149.3K (-27.1%) | 1.20% -0.165 pp | 0.00% 0.000 pp | USD2.50 -77.2% | 17 qtrs — |
| 7 | DEUTSCHE BANK AG\ | 525.4K +— (+0.0%) | 299.5K -63.0K (-17.4%) | 0.89% -0.004 pp | 0.00% +0.000 pp | USD4.94 -88.5% | 20 qtrs — |
| 8 | GEODE CAPITAL MANAGEMENT, LLC | 500.3K +5.1K (+1.0%) | 284.1K -56.6K (-16.6%) | 0.85% +0.005 pp | 0.00% +0.000 pp | USD8.88 -93.6% | 21 qtrs — |
| 9 | BLACKROCK, INC. | 480.9K +— (+0.0%) | 273.0K -57.8K (-17.5%) | 0.82% -0.003 pp | 0.00% +0.000 pp | USD1.68 -66.1% | 6 qtrs — |
| 10 | JANE STREET GROUP, LLC | 346.8K +152.4K (+78.4%) | 196.9K +63.2K (+47.2%) | 0.59% +0.258 pp | 0.00% +0.000 pp | USD0.64 -10.9% | 20 qtrs — |
| 11 | UBS GROUP AG | 225.7K +138.9K (+160.2%) | 128.2K +68.5K (+114.8%) | 0.38% +0.236 pp | 0.00% +0.000 pp | USD0.66 -13.6% | 14 qtrs — |
| 12 | ADAR1 CAPITAL MANAGEMENT, LLC | 183.1K +183.1K (+100.0%) | 104.0K +104.0K (+100.0%) | 0.31% +0.312 pp | 0.01% +0.008 pp | USD0.57 +0.0% | 3 qtrs — |
| 13 | STATE STREET CORP | 151.4K +— (+0.0%) | 85.9K -18.2K (-17.5%) | 0.26% -0.001 pp | 0.00% +0.000 pp | USD5.38 -89.4% | 20 qtrs — |
| 14 | SIMPLEX TRADING, LLC | 120.4K +84.2K (+233.0%) | 68.4K +44.4K (+184.9%) | 0.20% +0.143 pp | 0.00% +0.000 pp | USD0.57 +0.0% | 17 qtrs — |
| 15 | NORTHERN TRUST CORP | 103.5K +2.7K (+2.6%) | 58.8K -10.6K (-15.3%) | 0.18% +0.004 pp | 0.00% +0.000 pp | USD8.40 -93.2% | 20 qtrs — |
| 16 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 81.7K -170.9K (-67.7%) | 46.4K -127.4K (-73.3%) | 0.14% -0.293 pp | 0.00% +0.000 pp | USD0.99 -42.4% | 19 qtrs — |
| 17 | TWO SIGMA INVESTMENTS, LP | 81.3K +40.6K (+99.7%) | 46.2K +18.2K (+64.8%) | 0.14% +0.069 pp | 0.00% +0.000 pp | USD1.56 -63.5% | 17 qtrs — |
| 18 | PVG ASSET MANAGEMENT CORP | 69.0K +2.0K (+3.0%) | 39.2K -6.9K (-15.0%) | 0.12% +0.003 pp | 0.08% -0.086 pp | USD0.49 +16.3% | 5 qtrs — |
| 19 | XTX TOPCO LTD | 60.4K +41.0K (+211.6%) | 34.3K +21.0K (+157.2%) | 0.10% +0.070 pp | 0.00% +0.000 pp | USD0.61 -6.6% | 2 qtrs — |
| 20 | VIRTU FINANCIAL LLC | 55.5K +55.5K (+100.0%) | 31.0K +31.0K (+100.0%) | 0.09% +0.094 pp | 0.00% +0.001 pp | USD0.57 +0.0% | 1 qtrs NEW |
| 21 | HRT FINANCIAL LP | 54.7K +11.4K (+26.3%) | 31.0K +2.0K (+6.9%) | 0.09% +0.019 pp | 0.00% +0.000 pp | USD0.55 +3.6% | 7 qtrs — |
| 22 | MAI CAPITAL MANAGEMENT | 51.5K +6.4K (+14.2%) | 29.2K -1.8K (-5.7%) | 0.09% +0.011 pp | 0.00% +0.000 pp | USD0.87 -34.5% | 8 qtrs — |
| 23 | MORGAN STANLEY | 43.7K +28.2K (+183.0%) | 24.8K +14.2K (+133.5%) | 0.07% +0.048 pp | 0.00% +0.000 pp | USD3.58 -84.1% | 21 qtrs — |
| 24 | COLUMBIA ADVISORY PARTNERS LLC | 26.1K +— (+0.0%) | 14.8K -3.1K (-17.5%) | 0.04% 0.000 pp | 0.01% -0.002 pp | USD1.08 -47.2% | 6 qtrs — |
| 25 | COMMONWEALTH EQUITY SERVICES, LLC | 25.3K +— (+0.0%) | 14.4K -2.6K (-15.5%) | 0.04% 0.000 pp | 0.00% +0.000 pp | USD2.97 -80.8% | 8 qtrs — |
| 26 | MAGNUS FINANCIAL GROUP LLC | 20.0K -27.2K (-57.7%) | 11.4K -21.1K (-65.1%) | 0.03% -0.047 pp | 0.00% -0.002 pp | USD0.59 -3.4% | 5 qtrs — |
| 27 | — | 15.7K +1.0K (+6.8%) | 8.9K -1.2K (-11.5%) | 0.03% +0.002 pp | 0.00% +0.000 pp | USD0.68 -16.2% | 2 qtrs — |
| 28 | GLOBAL WEALTH STRATEGIES & ASSOCIATES | 13.8K +— (+0.0%) | 7.8K -1.7K (-17.5%) | 0.02% 0.000 pp | 0.00% -0.001 pp | USD0.59 -3.4% | 5 qtrs — |
| 29 | HIGHTOWER ADVISORS, LLC | 13.0K +— (+0.0%) | 7.4K -1.6K (-17.5%) | 0.02% 0.000 pp | 0.00% +0.000 pp | USD2.78 -79.5% | 15 qtrs — |
| 30 | TWIN LAKES CAPITAL MANAGEMENT, LLC | 9.0K +— (+0.0%) | 5.1K -1.1K (-17.5%) | 0.02% 0.000 pp | 0.00% -0.001 pp | USD7.78 -92.7% | 16 qtrs — |
| 31 | SBI SECURITIES CO., LTD. | 8.8K +1.3K (+17.9%) | 5.0K -139.0 (-2.7%) | 0.02% +0.002 pp | 0.00% +0.000 pp | USD0.47 +21.3% | 5 qtrs — |
| 32 | TOWER RESEARCH CAPITAL LLC (TRC) | 5.3K +5.3K (+100.0%) | 3.0K +3.0K (+100.0%) | 0.01% +0.009 pp | 0.00% +0.000 pp | USD0.57 +0.0% | 20 qtrs — |
| 33 | JONES FINANCIAL COMPANIES LLLP | 2.0K -325.0 (-14.0%) | 1.1K -421.0 (-27.1%) | 0.00% -0.001 pp | 0.00% +0.000 pp | USD0.69 -17.4% | 2 qtrs — |
| 34 | ARCADIA INVESTMENT MANAGEMENT CORP/MI | 1.4K +— (+0.0%) | 797.00 -169.0 (-17.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.59 -3.4% | 5 qtrs — |
| 35 | CIBC PRIVATE WEALTH GROUP, LLC | 1.3K +— (+0.0%) | 732.00 -155.0 (-17.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.39 -83.2% | 8 qtrs — |
| 36 | ADVISOR GROUP HOLDINGS, INC. | 500.00 +— (+0.0%) | 285.00 +60.0 (+26.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.40 +42.5% | 9 qtrs — |
| 37 | TUCKER ASSET MANAGEMENT LLC | 500.00 +500.0 (+100.0%) | 284.00 +284.0 (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD0.57 +0.0% | 1 qtrs NEW |
| 38 | BNP PARIBAS ARBITRAGE, SNC | 472.00 +— (+0.0%) | 268.00 -57.0 (-17.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.59 -3.4% | 5 qtrs — |
| 39 | BANK OF AMERICA CORP /DE/ | 432.00 +15.0 (+3.6%) | 245.00 -42.0 (-14.6%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.68 -66.1% | 21 qtrs — |
| 40 | JPMORGAN CHASE & CO | 129.00 -1.0K (-88.6%) | 73.00 -704.0 (-90.6%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD3.02 -81.1% | 21 qtrs — |
| 41 | NORTHROCK PARTNERS, LLC | — -20.8K (-100.0%) | — -14.3K (-100.0%) | 0.00% -0.036 pp | 0.00% 0.000 pp | USD— | 2 qtrs SOLD |
| 42 | TWO SIGMA SECURITIES, LLC | — -13.8K (-100.0%) | — -9.5K (-100.0%) | 0.00% -0.024 pp | 0.00% -0.001 pp | USD— | 2 qtrs SOLD |
| 43 | GROUP ONE TRADING, L.P. | — -1.2K (-100.0%) | — -795.0 (-100.0%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD— | 18 qtrs SOLD |
| 44 | CITIGROUP INC | — -26.1K (-100.0%) | — -18.0K (-100.0%) | 0.00% -0.045 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 45 | CITADEL ADVISORS LLC | — -274.0K (-100.0%) | — -188.5K (-100.0%) | 0.00% -0.468 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 46 | TANG CAPITAL MANAGEMENT LLC | — -1.4M (-100.0%) | — -945.2K (-100.0%) | 0.00% -2.349 pp | 0.00% -0.036 pp | USD— | 17 qtrs SOLD |
| 47 | BARCLAYS PLC | — -183.0 (-100.0%) | — -126.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 4 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 14 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Xtrackers CSI300 Swap UCITS ETF XCHA.L | 0.00% | 28.8K | 0.50% |
| 2 | Xtrackers - Xtrackers MSCI World Swap UCITS ETF 4C - EUR Hedged XWEH.DE | 0.00% | 12.0K | 0.39% |
| 3 | Xtrackers MSCI World Swap UCITS ETF 1C XMWD.L | 0.00% | 12.0K | 0.45% |
| 4 | Vanguard Extended Market ETF VXF | 0.00% | 35.2K | 0.05% |
| 5 | Vanguard U.S. Total Market Index ETF VUN.TO | 0.00% | 544.10 | 0.17% |
| 6 | Vanguard U.S. Total Market Index ETF (CAD-hedged) VUS.TO | 0.00% | 40.19 | 0.17% |
| 7 | Vanguard U.S. Total Market Shares Index ETF VTS.AX | 0.00% | 198.16 | 0.03% |
| 8 | Vanguard Total Stock Market ETF VTI | 0.00% | 93.2K | 0.03% |
| 9 | Vanguard All-Equity ETF Portfolio VEQT.TO | 0.00% | 203.53 | 0.22% |
| 10 | Vanguard Growth ETF Portfolio VGRO.TO | 0.00% | 111.30 | 0.22% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.75
Neutral
Ratio by volume
3.00
Bullish
Buys
3
Sells
4
Shares acquired
910.0K
Shares disposed
15.4K
Cash buys
—
Cash sales
—
Net activity
+894,601
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-11 | SHORT JAY M PHD | Director / Officer | A-Award | A | Common Stock | 430,000 | 0.00 | — | 2,659,603 | D | ↗ |
| 2026-03-10 | Vasquez Christian | Officer | A-Award | A | Common Stock | 240,000 | 0.00 | — | 530,196 | D | ↗ |
| 2026-03-10 | Sievers Eric | Officer | A-Award | A | Common Stock | 240,000 | 0.00 | — | 598,705 | D | ↗ |
| 2026-02-28 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 2,729 | 0.25 | 674.06 | 343,421 | D | ↗ |
| 2026-02-28 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 1,802 | 0.25 | 445.09 | 290,196 | D | ↗ |
| 2026-02-28 | Sievers Eric | Officer | F-InKind | D | Common Stock | 3,140 | 0.25 | 775.58 | 358,705 | D | ↗ |
| 2026-02-28 | SHORT JAY M PHD | Director / Officer | F-InKind | D | Common Stock | 7,728 | 0.25 | 1.9K | 2,229,603 | D | ↗ |
| 2025-11-30 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 2,371 | 0.90 | 2.1K | 346,150 | D | ↗ |
| 2025-11-30 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 1,566 | 0.90 | 1.4K | 291,998 | D | ↗ |
| 2025-11-30 | Sievers Eric | Officer | F-InKind | D | Common Stock | 2,729 | 0.90 | 2.5K | 361,845 | D | ↗ |
| 2025-11-30 | SHORT JAY M PHD | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 6,347 | 0.90 | 5.7K | 2,237,331 | D | ↗ |
| 2025-08-31 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 2,371 | 0.46 | 1.1K | 338,521 | D | ↗ |
| 2025-08-31 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 1,566 | 0.46 | 713.31 | 283,564 | D | ↗ |
| 2025-08-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 2,729 | 0.46 | 1.2K | 364,574 | D | ↗ |
| 2025-08-31 | SHORT JAY M PHD | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 6,347 | 0.46 | 2.9K | 2,243,678 | D | ↗ |
| 2025-06-18 | Williams Eddie | Director | A-Award | A | Common Stock | 23,500 | 0.00 | — | 60,200 | D | ↗ |
| 2025-06-18 | Smith Scott Andrew | Director | A-Award | A | Common Stock | 23,500 | 0.00 | — | 321,550 | D | ↗ |
| 2025-06-18 | STEINMAN LAWRENCE | Director | A-Award | A | Common Stock | 23,500 | 0.00 | — | 78,459 | D | ↗ |
| 2025-06-18 | Moran Susan | Director | A-Award | A | Common Stock | 23,500 | 0.00 | — | 52,307 | D | ↗ |
| 2025-06-18 | MCBRINN SYLVIA | Director | A-Award | A | Common Stock | 23,500 | 0.00 | — | 59,125 | D | ↗ |
| 2025-06-18 | GRAY MARY ANN | Director | A-Award | A | Common Stock | 23,500 | 0.00 | — | 77,397 | D | ↗ |
| 2025-05-31 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 2,371 | 0.41 | 969.74 | 340,892 | D | ↗ |
| 2025-05-31 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 1,566 | 0.41 | 640.49 | 285,130 | D | ↗ |
| 2025-05-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 2,729 | 0.41 | 1.1K | 367,303 | D | ↗ |
| 2025-05-31 | SHORT JAY M PHD | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 6,347 | 0.41 | 2.6K | 2,250,025 | D | ↗ |
| 2025-03-12 | SHORT JAY M PHD | Director / Officer / 10% Owner | A-Award | A | Common Stock | 431,000 | 0.00 | — | 2,256,372 | D | ↗ |
| 2025-03-11 | WALDRON RICHARD A | Officer | A-Award | A | Common Stock | 100,000 | 0.00 | — | 333,263 | D | ↗ |
| 2025-03-11 | Vasquez Christian | Officer | A-Award | A | Common Stock | 85,000 | 0.00 | — | 276,696 | D | ↗ |
| 2025-03-11 | Sievers Eric | Officer | A-Award | A | Common Stock | 175,000 | 0.00 | — | 370,032 | D | ↗ |
| 2025-02-16 | SHORT JAY M PHD | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 30,911 | 0.46 | 14.2K | 1,825,372 | D | ↗ |
| 2025-02-15 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 10,887 | 0.46 | 5.0K | 233,263 | D | ↗ |
| 2025-02-15 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 7,189 | 0.46 | 3.3K | 191,696 | D | ↗ |
| 2025-02-15 | Sievers Eric | Officer | F-InKind | D | Common Stock | 12,530 | 0.46 | 5.8K | 195,032 | D | ↗ |
| 2024-08-31 | Smith Scott Andrew | Director | F-InKind | D | Common Stock | 2,181 | 1.77 | 3.9K | 298,050 | — | ↗ |
| 2024-08-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 572 | 1.77 | 1.0K | 207,562 | — | ↗ |
| 2024-07-31 | Smith Scott Andrew | Director | F-InKind | D | Common Stock | 2,181 | 1.81 | 3.9K | 300,231 | — | ↗ |
| 2024-07-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 572 | 1.81 | 1.0K | 208,134 | — | ↗ |
| 2024-06-30 | Smith Scott Andrew | Director | F-InKind | D | Common Stock | 2,181 | 1.37 | 3.0K | 302,412 | — | ↗ |
| 2024-06-30 | Sievers Eric | Officer | F-InKind | D | Common Stock | 572 | 1.37 | 783.64 | 208,706 | — | ↗ |
| 2024-06-13 | Williams Eddie | Director | A-Award | A | Common Stock | 16,500 | 0.00 | — | 36,700 | — | ↗ |
| 2024-06-13 | Smith Scott Andrew | Director | A-Award | A | Common Stock | 16,500 | 0.00 | — | 304,593 | — | ↗ |
| 2024-06-13 | STEINMAN LAWRENCE | Director | A-Award | A | Common Stock | 16,500 | 0.00 | — | 54,959 | — | ↗ |
| 2024-06-13 | Moran Susan | Director | A-Award | A | Common Stock | 16,500 | 0.00 | — | 28,807 | — | ↗ |
| 2024-06-13 | MCBRINN SYLVIA | Director | A-Award | A | Common Stock | 16,500 | 0.00 | — | 35,625 | — | ↗ |
| 2024-06-13 | GRAY MARY ANN | Director | A-Award | A | Common Stock | 16,500 | 0.00 | — | 53,897 | — | ↗ |
| 2024-05-31 | Smith Scott Andrew | Director | F-InKind | D | Common Stock | 2,181 | 1.51 | 3.3K | 288,093 | — | ↗ |
| 2024-05-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 572 | 1.51 | 863.72 | 209,278 | — | ↗ |
| 2024-04-30 | Smith Scott Andrew | Director | F-InKind | D | Common Stock | 2,181 | 2.26 | 4.9K | 290,274 | — | ↗ |
| 2024-04-30 | Sievers Eric | Officer | F-InKind | D | Common Stock | 572 | 2.26 | 1.3K | 209,850 | — | ↗ |
| 2024-03-31 | Smith Scott Andrew | Director | F-InKind | D | Common Stock | 2,181 | 3.44 | 7.5K | 292,455 | — | ↗ |
| 2024-03-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 572 | 3.44 | 2.0K | 210,422 | — | ↗ |
| 2024-02-29 | Smith Scott Andrew | Director | F-InKind | D | Common Stock | 2,181 | 2.70 | 5.9K | 294,636 | — | ↗ |
| 2024-02-29 | Sievers Eric | Officer | F-InKind | D | Common Stock | 572 | 2.70 | 1.5K | 210,994 | — | ↗ |
| 2024-02-16 | SHORT JAY M PHD | Director / Officer / 10% Owner | A-Award | A | Common Stock | 417,000 | 0.00 | — | 1,856,283 | — | ↗ |
| 2024-02-15 | WALDRON RICHARD A | Officer | A-Award | A | Common Stock | 106,000 | 0.00 | — | 230,923 | — | ↗ |
| 2024-02-15 | Vasquez Christian | Officer | A-Award | A | Common Stock | 70,000 | 0.00 | — | 185,659 | — | ↗ |
| 2024-02-15 | Sievers Eric | Officer | A-Award | A | Common Stock | 122,000 | 0.00 | — | 211,566 | — | ↗ |
| 2024-01-31 | Smith Scott Andrew | Director | F-InKind | D | Common Stock | 2,181 | 1.92 | 4.2K | 296,817 | — | ↗ |
| 2024-01-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 657 | 1.92 | 1.3K | 89,566 | — | ↗ |
| 2023-12-31 | Williams Eddie | Director | A-Award | A | Common Stock | 4,827 | 0.00 | — | 20,200 | — | ↗ |
| 2023-12-31 | Smith Scott Andrew | Director | F-InKind | D | Common Stock | 1,791 | 2.46 | 4.4K | 298,998 | — | ↗ |
| 2023-12-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 555 | 2.46 | 1.4K | 90,223 | — | ↗ |
| 2023-12-31 | GRAY MARY ANN | Director | A-Award | A | Common Stock | 5,995 | 0.00 | — | 37,397 | — | ↗ |
| 2023-12-26 | MCBRINN SYLVIA | Director | P-Purchase | A | Common Stock | 4,000 | 2.33 | 9.3K | 15,125 | — | ↗ |
| 2023-12-20 | SHORT JAY M PHD | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 50,000 | 2.14 | 106.9K | 1,439,283 | — | ↗ |
| 2023-12-19 | Vasquez Christian | Officer | P-Purchase | A | Common Stock | 7,495 | 2.04 | 15.3K | 115,659 | — | ↗ |
| 2023-12-19 | STEINMAN LAWRENCE | Director | P-Purchase | A | Common Stock | 20,000 | 2.05 | 41.0K | 38,459 | — | ↗ |
| 2023-11-30 | Smith Scott Andrew | Director | F-InKind | D | Common Stock | 1,791 | 1.77 | 3.2K | 300,789 | — | ↗ |
| 2023-11-30 | Sievers Eric | Officer | F-InKind | D | Common Stock | 554 | 1.77 | 980.58 | 90,778 | — | ↗ |
| 2023-10-31 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 1.47 | 1.4K | 124,923 | — | ↗ |
| 2023-10-31 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 194 | 1.47 | 285.18 | 101,162 | — | ↗ |
| 2023-10-31 | Smith Scott Andrew | Director | F-InKind | D | Common Stock | 1,791 | 1.47 | 2.6K | 302,580 | — | ↗ |
| 2023-10-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 555 | 1.47 | 815.85 | 91,332 | — | ↗ |
| 2023-10-31 | SHORT JAY M PHD | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,888 | 1.47 | 4.2K | 1,389,283 | — | ↗ |
| 2023-09-30 | Williams Eddie | Director | A-Award | A | Common Stock | 6,985 | 0.00 | — | 15,373 | — | ↗ |
| 2023-09-30 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 1.70 | 1.6K | 125,893 | — | ↗ |
| 2023-09-30 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 194 | 1.70 | 329.80 | 101,356 | — | ↗ |
| 2023-09-30 | Smith Scott Andrew | Director | F-InKind | D | Common Stock | 1,791 | 1.70 | 3.0K | 304,371 | — | ↗ |
| 2023-09-30 | Sievers Eric | Officer | F-InKind | D | Common Stock | 554 | 1.70 | 941.80 | 91,887 | — | ↗ |
| 2023-09-30 | SHORT JAY M PHD | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,888 | 1.70 | 4.9K | 1,392,171 | — | ↗ |
| 2023-09-30 | GRAY MARY ANN | Director | A-Award | A | Common Stock | 8,676 | 0.00 | — | 31,402 | — | ↗ |
| 2023-09-08 | MCBRINN SYLVIA | Director | P-Purchase | A | Common Stock | 2,000 | 2.54 | 5.1K | 11,125 | — | ↗ |
| 2023-08-31 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 2.51 | 2.4K | 126,863 | — | ↗ |
| 2023-08-31 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 194 | 2.51 | 486.94 | 101,550 | — | ↗ |
| 2023-08-31 | Smith Scott Andrew | Director | F-InKind | D | Common Stock | 1,791 | 2.51 | 4.5K | 306,162 | — | ↗ |
| 2023-08-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 555 | 2.51 | 1.4K | 92,441 | — | ↗ |
| 2023-08-31 | SHORT JAY M PHD | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,888 | 2.51 | 7.2K | 1,395,059 | — | ↗ |
| 2023-07-31 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 2.99 | 2.9K | 127,833 | — | ↗ |
| 2023-07-31 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 194 | 2.99 | 580.06 | 101,744 | — | ↗ |
| 2023-07-31 | Smith Scott Andrew | Director | F-InKind | D | Common Stock | 1,791 | 2.99 | 5.4K | 307,953 | — | ↗ |
| 2023-07-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 554 | 2.99 | 1.7K | 92,996 | — | ↗ |
| 2023-07-31 | SHORT JAY M PHD | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,888 | 2.99 | 8.6K | 1,397,947 | — | ↗ |
| 2023-06-30 | Williams Eddie | Director | A-Award | A | Common Stock | 3,958 | 0.00 | — | 8,388 | — | ↗ |
| 2023-06-30 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 3.00 | 2.9K | 125,780 | — | ↗ |
| 2023-06-30 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 194 | 3.00 | 582.00 | 101,938 | — | ↗ |
| 2023-06-30 | Smith Scott Andrew | Director | F-InKind | D | Common Stock | 1,791 | 3.00 | 5.4K | 309,744 | — | ↗ |
| 2023-06-30 | Sievers Eric | Officer | F-InKind | D | Common Stock | 555 | 3.00 | 1.7K | 90,527 | — | ↗ |
| 2023-06-30 | SHORT JAY M PHD | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,888 | 3.00 | 8.7K | 1,400,835 | — | ↗ |
| 2023-06-30 | GRAY MARY ANN | Director | A-Award | A | Common Stock | 4,916 | 0.00 | — | 22,726 | — | ↗ |
| 2023-06-14 | Williams Eddie | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 3.55 | 177.5K | 50,000 | — | ↗ |
| 2023-06-14 | Smith Scott Andrew | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 3.55 | 177.5K | 50,000 | — | ↗ |
| 2023-06-14 | STEINMAN LAWRENCE | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 3.55 | 177.5K | 50,000 | — | ↗ |
| 2023-06-14 | Moran Susan | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 3.55 | 177.5K | 50,000 | — | ↗ |
| 2023-06-14 | MCBRINN SYLVIA | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 3.55 | 177.5K | 50,000 | — | ↗ |
| 2023-06-14 | GRAY MARY ANN | Director | A-Award | A | Stock Option (Right to Buy) | 50,000 | 3.55 | 177.5K | 50,000 | — | ↗ |
| 2023-05-31 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 3.15 | 3.1K | 126,750 | — | ↗ |
| 2023-05-31 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 194 | 3.15 | 611.10 | 102,132 | — | ↗ |
| 2023-05-31 | Smith Scott Andrew | Director | F-InKind | D | Common Stock | 1,791 | 3.15 | 5.6K | 311,535 | — | ↗ |
| 2023-05-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 554 | 3.15 | 1.7K | 91,082 | — | ↗ |
| 2023-05-31 | SHORT JAY M PHD | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,888 | 3.15 | 9.1K | 1,403,723 | — | ↗ |
| 2023-04-30 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 3.37 | 3.3K | 127,720 | — | ↗ |
| 2023-04-30 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 194 | 3.37 | 653.78 | 102,326 | — | ↗ |
| 2023-04-30 | Smith Scott Andrew | Director | F-InKind | D | Common Stock | 1,791 | 3.37 | 6.0K | 313,326 | — | ↗ |
| 2023-04-30 | Sievers Eric | Officer | F-InKind | D | Common Stock | 555 | 3.37 | 1.9K | 91,636 | — | ↗ |
| 2023-04-30 | SHORT JAY M PHD | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,888 | 3.37 | 9.7K | 1,406,611 | — | ↗ |
| 2023-03-31 | Williams Eddie | Director | A-Award | A | Common Stock | 4,430 | 0.00 | — | 4,430 | — | ↗ |
| 2023-03-31 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 2.68 | 2.6K | 128,690 | — | ↗ |
| 2023-03-31 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 189 | 2.68 | 506.52 | 102,520 | — | ↗ |
| 2023-03-31 | Smith Scott Andrew | Director / Officer | F-InKind | D | Common Stock | 1,791 | 2.68 | 4.8K | 315,117 | — | ↗ |
| 2023-03-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 555 | 2.68 | 1.5K | 92,191 | — | ↗ |
| 2023-03-31 | SHORT JAY M PHD | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,888 | 2.68 | 7.7K | 1,409,499 | — | ↗ |
| 2023-03-31 | GRAY MARY ANN | Director | A-Award | A | Common Stock | 5,503 | 0.00 | — | 17,810 | — | ↗ |
| 2023-03-29 | SHORT JAY M PHD | Director / Officer / 10% Owner | P-Purchase | A | Common Stock | 40,800 | 2.47 | 100.9K | 1,412,387 | — | ↗ |
| 2023-03-28 | Vasquez Christian | Officer | P-Purchase | A | Common Stock | 20,000 | 2.40 | 48.0K | 102,709 | — | ↗ |
| 2023-03-28 | MCBRINN SYLVIA | Director | P-Purchase | A | Common Stock | 4,000 | 2.35 | 9.4K | 19,125 | — | ↗ |
| 2023-02-28 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 2.98 | 2.9K | 129,660 | — | ↗ |
| 2023-02-28 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 229 | 2.98 | 682.42 | 82,709 | — | ↗ |
| 2023-02-28 | Smith Scott Andrew | Director / Officer | F-InKind | D | Common Stock | 1,791 | 2.98 | 5.3K | 316,908 | — | ↗ |
| 2023-02-28 | Sievers Eric | Officer | F-InKind | D | Common Stock | 554 | 2.98 | 1.7K | 92,746 | — | ↗ |
| 2023-02-28 | SHORT JAY M PHD | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,888 | 2.89 | 8.3K | 1,371,587 | — | ↗ |
| 2023-02-10 | Smith Scott Andrew | Director / Officer | A-Award | A | Employee Stock Option (right to buy) | 350,000 | 3.65 | 1.28M | 350,000 | — | ↗ |
| 2023-02-10 | SHORT JAY M PHD | Director / Officer / 10% Owner | A-Award | A | Employee Stock Option (right to buy) | 850,000 | 3.65 | 3.10M | 850,000 | — | ↗ |
| 2023-02-09 | WALDRON RICHARD A | Officer | A-Award | A | Employee Stock Option (right to buy) | 210,000 | 3.95 | 829.5K | 210,000 | — | ↗ |
| 2023-02-09 | Vasquez Christian | Officer | A-Award | A | Employee Stock Option (right to buy) | 135,000 | 3.95 | 533.3K | 135,000 | — | ↗ |
| 2023-02-09 | Sievers Eric | Officer | A-Award | A | Employee Stock Option (right to buy) | 240,000 | 3.95 | 948.0K | 240,000 | — | ↗ |
| 2023-01-31 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 1,144 | 3.79 | 4.3K | 130,630 | — | ↗ |
| 2023-01-31 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 229 | 3.79 | 867.91 | 82,938 | — | ↗ |
| 2023-01-31 | Smith Scott Andrew | Director / Officer | F-InKind | D | Common Stock | 2,181 | 3.79 | 8.3K | 318,699 | — | ↗ |
| 2023-01-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 654 | 3.79 | 2.5K | 93,300 | — | ↗ |
| 2023-01-31 | SHORT JAY M PHD | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 3,517 | 3.79 | 13.3K | 1,374,475 | — | ↗ |
| 2022-12-31 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 8.25 | 8.0K | 131,774 | — | ↗ |
| 2022-12-31 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 194 | 8.25 | 1.6K | 83,167 | — | ↗ |
| 2022-12-31 | Smith Scott Andrew | Officer | F-InKind | D | Common Stock | 1,791 | 8.25 | 14.8K | 320,880 | — | ↗ |
| 2022-12-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 554 | 8.25 | 4.6K | 93,954 | — | ↗ |
| 2022-12-31 | SHORT JAY M PHD | Officer | F-InKind | D | Common Stock | 4,667 | 8.25 | 38.5K | 1,377,992 | — | ↗ |
| 2022-12-19 | MCBRINN SYLVIA | Director | P-Purchase | A | Common Stock | 3,700 | 8.33 | 30.8K | 9,125 | — | ↗ |
| 2022-11-30 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 11.01 | 10.7K | 132,744 | — | ↗ |
| 2022-11-30 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 194 | 11.01 | 2.1K | 83,361 | — | ↗ |
| 2022-11-30 | Smith Scott Andrew | Officer | F-InKind | D | Common Stock | 1,791 | 11.01 | 19.7K | 322,671 | — | ↗ |
| 2022-11-30 | Sievers Eric | Officer | F-InKind | D | Common Stock | 555 | 11.01 | 6.1K | 94,508 | — | ↗ |
| 2022-11-30 | SHORT JAY M PHD | Officer | F-InKind | D | Common Stock | 4,667 | 11.01 | 51.4K | 1,382,659 | — | ↗ |
| 2022-11-22 | MCBRINN SYLVIA | Director | P-Purchase | A | Common Stock | 2,000 | 8.27 | 16.5K | 5,425 | — | ↗ |
| 2022-10-31 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 6.89 | 6.7K | 123,714 | — | ↗ |
| 2022-10-31 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 194 | 6.89 | 1.3K | 73,555 | — | ↗ |
| 2022-10-31 | Smith Scott Andrew | Officer | F-InKind | D | Common Stock | 1,791 | 6.89 | 12.3K | 324,462 | — | ↗ |
| 2022-10-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 554 | 6.89 | 3.8K | 85,063 | — | ↗ |
| 2022-10-31 | SHORT JAY M PHD | Officer | F-InKind | D | Common Stock | 3,454 | 6.89 | 23.8K | 1,387,326 | — | ↗ |
| 2022-09-30 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 7.70 | 7.5K | 124,684 | — | ↗ |
| 2022-09-30 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 194 | 7.70 | 1.5K | 73,749 | — | ↗ |
| 2022-09-30 | Smith Scott Andrew | Officer | F-InKind | D | Common Stock | 1,791 | 7.70 | 13.8K | 326,253 | — | ↗ |
| 2022-09-30 | Sievers Eric | Officer | F-InKind | D | Common Stock | 555 | 7.70 | 4.3K | 85,617 | — | ↗ |
| 2022-09-30 | SHORT JAY M PHD | Officer | F-InKind | D | Common Stock | 2,888 | 7.70 | 22.2K | 1,390,780 | — | ↗ |
| 2022-08-31 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 8.71 | 8.4K | 125,654 | — | ↗ |
| 2022-08-31 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 194 | 8.71 | 1.7K | 73,943 | — | ↗ |
| 2022-08-31 | Smith Scott Andrew | Officer | F-InKind | D | Common Stock | 1,791 | 8.71 | 15.6K | 328,044 | — | ↗ |
| 2022-08-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 555 | 8.71 | 4.8K | 86,172 | — | ↗ |
| 2022-08-31 | SHORT JAY M PHD | Officer | F-InKind | D | Common Stock | 2,888 | 8.71 | 25.2K | 1,393,668 | — | ↗ |
| 2022-08-12 | SHORT JAY M PHD | Officer | P-Purchase | A | Common Stock | 26,350 | 7.84 | 206.6K | 1,396,556 | — | ↗ |
| 2022-07-31 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 3.40 | 3.3K | 126,624 | — | ↗ |
| 2022-07-31 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 194 | 3.40 | 659.60 | 74,137 | — | ↗ |
| 2022-07-31 | Smith Scott Andrew | Officer | F-InKind | D | Common Stock | 1,791 | 3.40 | 6.1K | 329,835 | — | ↗ |
| 2022-07-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 554 | 3.40 | 1.9K | 86,727 | — | ↗ |
| 2022-07-31 | SHORT JAY M PHD | Officer | F-InKind | D | Common Stock | 2,888 | 3.40 | 9.8K | 1,370,206 | — | ↗ |
| 2022-06-30 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 2.85 | 2.8K | 127,594 | — | ↗ |
| 2022-06-30 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 194 | 2.85 | 552.90 | 74,331 | — | ↗ |
| 2022-06-30 | Smith Scott Andrew | Officer | F-InKind | D | Common Stock | 1,791 | 2.85 | 5.1K | 331,626 | — | ↗ |
| 2022-06-30 | Sievers Eric | Officer | F-InKind | D | Common Stock | 555 | 2.85 | 1.6K | 87,281 | — | ↗ |
| 2022-06-30 | SHORT JAY M PHD | Officer | F-InKind | D | Common Stock | 2,888 | 2.85 | 8.2K | 1,373,094 | — | ↗ |
| 2022-06-21 | SHORT JAY M PHD | Officer | P-Purchase | A | Common Stock | 40,308 | 2.91 | 117.3K | 1,375,982 | — | ↗ |
| 2022-06-16 | Williams Eddie | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.48 | 49.6K | 20,000 | — | ↗ |
| 2022-06-16 | STEINMAN LAWRENCE | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.48 | 49.6K | 20,000 | — | ↗ |
| 2022-06-16 | Moran Susan | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2022-06-16 | MCBRINN SYLVIA | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2022-06-16 | Levy Guy | — | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2022-06-16 | GRAY MARY ANN | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 0.00 | — | 20,000 | — | ↗ |
| 2022-06-07 | Vasquez Christian | Officer | P-Purchase | A | Common Stock | 10,000 | 2.97 | 29.7K | 74,525 | — | ↗ |
| 2022-05-31 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 2.41 | 2.3K | 128,564 | — | ↗ |
| 2022-05-31 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 194 | 2.41 | 467.54 | 24,525 | — | ↗ |
| 2022-05-31 | Smith Scott Andrew | Officer | F-InKind | D | Common Stock | 1,791 | 2.41 | 4.3K | 333,417 | — | ↗ |
| 2022-05-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 554 | 2.41 | 1.3K | 87,836 | — | ↗ |
| 2022-05-31 | SHORT JAY M PHD | Director / Officer / 10% Owner | F-InKind | D | Common Stock | 2,888 | 2.41 | 7.0K | 1,306,592 | — | ↗ |
| 2022-04-30 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 3.48 | 3.4K | 129,534 | — | ↗ |
| 2022-04-30 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 189 | 3.48 | 657.72 | 24,719 | — | ↗ |
| 2022-04-30 | Smith Scott Andrew | Officer | F-InKind | D | Common Stock | 1,791 | 3.48 | 6.2K | 335,208 | — | ↗ |
| 2022-04-30 | Sievers Eric | Officer | F-InKind | D | Common Stock | 555 | 3.48 | 1.9K | 88,390 | — | ↗ |
| 2022-04-30 | SHORT JAY M PHD | Officer | F-InKind | D | Common Stock | 2,888 | 3.48 | 10.1K | 1,304,102 | — | ↗ |
| 2022-03-31 | WALDRON RICHARD A | Officer | F-InKind | D | Common Stock | 970 | 5.00 | 4.9K | 130,504 | — | ↗ |
| 2022-03-31 | Vasquez Christian | Officer | F-InKind | D | Common Stock | 189 | 5.00 | 945.00 | 24,908 | — | ↗ |
| 2022-03-31 | Smith Scott Andrew | Officer | F-InKind | D | Common Stock | 1,791 | 5.00 | 9.0K | 336,999 | — | ↗ |
| 2022-03-31 | Sievers Eric | Officer | F-InKind | D | Common Stock | 554 | 5.00 | 2.8K | 88,945 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-9.7K
Shares Outstanding
1.18M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | Jay M. Short, Ph.D. Chief Executive Officer, Cofounder, and Chairman of the Board of Directors | 734.8K | — | 942.4K | — | 275.6K | — | 1.95M | 48.26% | ↗ |
| 2 | 2024 | Eric Sievers, M.D. Chief Medical Officer | 510.2K | — | 323.3K | — | 127.6K | — | 961.1K | 33.64% | ↗ |
| 3 | 2024 | Richard A. Waldron Chief Financial Officer | 480.6K | — | 280.9K | — | 120.2K | — | 881.7K | 31.86% | ↗ |
| 4 | 2023 | Jay M. Short, Ph.D. Chief Executive Officer, Cofounder, and Chairman of the Board of Directors | 713.4K | — | — | 2.17M | 419.5K | — | 3.30M | 65.68% | ↗ |
| 5 | 2023 | Eric Sievers, M.D. Chief Medical Officer | 470.3K | — | — | 662.3K | 184.3K | — | 1.32M | 50.29% | ↗ |
| 6 | 2023 | Scott Smith Former President, Director | 97.4K | — | — | 1.15M | — | 23.6K | 1.27M | 90.49% | ↗ |
| 7 | 2023 | Richard A. Waldron Chief Financial Officer | 471.2K | — | — | 579.5K | 184.7K | — | 1.24M | 46.91% | ↗ |
| 8 | 2022 | Jay M. Short, Ph.D. Chief Executive Officer, Cofounder, and Chairman of the Board of Directors | 686.0K | 1.4K | — | 1.49M | 370.4K | — | 2.54M | 58.43% | ↗ |
| 9 | 2022 | Scott Smith President | 572.3K | 1.4K | — | 882.2K | 257.5K | — | 1.71M | 51.49% | ↗ |
| 10 | 2022 | Scott Smith Former President, Director | 572.3K | 1.4K | — | 882.2K | 257.5K | — | 1.71M | 51.49% | ↗ |
| 11 | 2022 | Eric Sievers, M.D. Chief Medical Officer | 446.2K | 1.4K | — | 545.3K | 160.6K | — | 1.15M | 47.27% | ↗ |
| 12 | 2022 | Richard A. Waldron Chief Financial Officer | 453.1K | 1.4K | — | 514.0K | 163.1K | — | 1.13M | 45.42% | ↗ |
| 13 | 2022 | Christian Vasquez Vice President of Finance, Corporate Controller and Secretary | 317.0K | 1.4K | — | 196.7K | 90.3K | — | 605.4K | 32.48% | ↗ |
| 14 | 2021 | Carolyn Anderson Short Co-founder, Former Executive Vice President and Chief of Intellectual Property and Strategy | 239.0K | — | — | — | — | 7.13M | 7.37M | 0.00% | ↗ |
| 15 | 2021 | Jay M. Short, Ph.D. Chief Executive Officer, Cofounder, and Chairman of the Board of Directors | 659.6K | 1.0K | — | — | 356.2K | — | 1.02M | 0.00% | ↗ |
| 16 | 2021 | Jay M. Short, Ph.D. Chief Executive Officer, Founder and Chairman of the Board of Directors | 659.6K | 1.0K | — | — | 356.2K | — | 1.02M | 0.00% | ↗ |
| 17 | 2021 | Scott Smith President | 550.3K | 1.0K | — | — | 247.6K | — | 798.9K | 0.00% | ↗ |
| 18 | 2021 | Richard A. Waldron Chief Financial Officer | 435.7K | 1.0K | — | — | 156.8K | — | 593.5K | 0.00% | ↗ |
| 19 | 2021 | Eric Sievers, M.D. Chief Medical Officer | 405.6K | 1.0K | — | — | 146.0K | — | 552.6K | 0.00% | ↗ |
| 20 | 2021 | Christian Vasquez Vice President of Finance, Corporate Controller and Secretary | 266.8K | 1.0K | — | — | 78.1K | — | 345.9K | 0.00% | ↗ |
| 21 | 2020 | Jay M. Short, Ph.D. Chief Executive Officer, Cofounder, and Chairman of the Board of Directors | 636.0K | 3.0K | 10.25M | 361.4K | 418.6K | — | 11.67M | 90.93% | ↗ |
| 22 | 2020 | Jay M. Short, Ph.D. Co-founder, Chief Executive Officer and Chairman | 636.0K | — | 10.25M | 361.4K | 421.6K | — | 11.67M | 90.93% | ↗ |
| 23 | 2020 | Jay M. Short, Ph.D. Chief Executive Officer, Founder and Chairman of the Board of Directors | 636.0K | 3.0K | 10.25M | 361.4K | 418.6K | — | 11.67M | 90.93% | ↗ |
| 24 | 2020 | Scott Smith President and Director | 530.5K | — | 6.35M | 1.81M | 294.0K | — | 8.99M | 90.82% | ↗ |
| 25 | 2020 | Scott Smith President | 530.5K | 3.0K | 6.35M | 1.81M | 291.0K | — | 8.99M | 90.82% | ↗ |
| 26 | 2020 | Carolyn Anderson Short Co-founder, Former Executive Vice President and Chief of Intellectual Property and Strategy | 552.9K | 3.0K | 2.49M | 90.4K | 303.3K | — | 3.44M | 75.04% | ↗ |
| 27 | 2020 | Carolyn Anderson Short Co-founder, Executive Vice President and Chief of Intellectual Property and Strategy | 552.9K | — | 2.49M | 90.4K | 306.3K | — | 3.44M | 75.04% | ↗ |
| 28 | 2019 | Jay M. Short, Ph.D. Chief Executive Officer, Founder and Chairman of the Board of Directors | 609.8K | 381.6K | — | — | — | — | 991.5K | 0.00% | ↗ |
| 29 | 2019 | Jay M. Short, Ph.D. Co-founder, Chief Executive Officer and Chairman | 609.8K | 348.5K | — | — | — | — | 958.3K | 0.00% | ↗ |
| 30 | 2019 | Scott Smith President | 508.8K | 290.3K | — | — | — | — | 799.1K | 0.00% | ↗ |
| 31 | 2019 | Carolyn Anderson Short Co-founder, Former Executive Vice President and Chief of Intellectual Property and Strategy | 510.4K | 266.1K | — | — | — | — | 776.6K | 0.00% | ↗ |
| 32 | 2019 | Carolyn Anderson Short Co-founder, Executive Vice President and Chief of Intellectual Property and Strategy | 510.4K | 193.2K | — | — | — | — | 703.6K | 0.00% | ↗ |
| 33 | 2019 | Scott Smith President and Director | 508.8K | 67.9K | — | — | — | — | 576.6K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jay Short | Co-Founder, Chief Executive Officer & Chairman | 734.8K | — |
| Eric L. Sievers | Chief Medical Officer | 530.6K | — |
| Christian Vasquez | CFO & Chief Accounting Officer | 408.7K | male |
| Monica Sullivan | Senior Vice President of Intellectual Property & Contracts | — | female |
| Sheri Lydick | Chief Commercial Officer | — | female |
| Cathy Chang | Senior Vice President of Research & Development | — | — |
| Susie Melody | Senior Vice President of Human Resources | — | female |
| Gerhard Frey | Senior Vice President of Technology Development | — | — |
| Lisa Pelton | Accounting Manager | — | — |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for BCAB
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
